Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study

Fixed-duration glofitamab induced high CR rates in heavily pretreated patients with R/R MCL; the safety profile was manageable with appropriate support.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-10-04
DOI
https://doi.org/10.1200/jco.23.02470
Citations
46
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
19.55

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study

Jan Maciej Zaucha, Ben E. Byrne, Tomasz Wróbel, Carmelo Carlo‐Stella et al.
46 citations
Journal of Clinical Oncology
Lymphoma Diagnosis and Treatment
19.55
article

Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study

Jan Maciej Zaucha, Ben E. Byrne, Tomasz Wróbel, Carmelo Carlo‐Stella, Franck Morschhauser, Naseer Qayum, Emmanuel Bachy, Michael Crump, Tycel Phillips, Linda Lundberg, James Relf, Nancy L. Bartlett, David Carlile, Marek Trněný, Michael John Dickinson, Audrey Filézac de L’Etang, Kathryn Humphrey, Fritz Offner
article en
46 citations

Abstract

Fixed-duration glofitamab induced high CR rates in heavily pretreated patients with R/R MCL; the safety profile was manageable with appropriate support.

Journal of Clinical OncologyVol. 43(3)
Université Claude Bernard Lyon 1 (FR), Roche (Switzerland) (CH), City Of Hope National Medical Center (US), The Royal Melbourne Hospital (AU), Humanitas University (IT), The University of Melbourne (AU), Washington University in St. Louis (US), Charles University (CZ), University of Michigan (US), Universitair Ziekenhuis Leuven (BE), Peter MacCallum Cancer Centre (AU), Princess Margaret Cancer Centre (CA), Centre Hospitalier Universitaire de Lille (FR), Wroclaw Medical University (PL), Hospices Civils de Lyon (FR), Roche (United Kingdom) (GB), Universitair Ziekenhuis Brussel (BE), IRCCS Humanitas Research Hospital (IT), Gdańsk Medical University (PL)
F. Hoffmann-La Roche
Openalex Percentile: Top 0%
Lymphoma Diagnosis and Treatment
19.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.